Business context and reporting period
The filing is for NortonLifeLock Inc. (ticker NLOK), the registrant named in the 10-Q; the reporting period is its third quarter of fiscal 2022, ended December 31, 2021, with comparisons to the quarter ended January 1, 2021. The company provides consumer cybersecurity, identity and information-protection services. It reported one operating segment. The filing does not use the name Gen Digital.
Financial performance and position
Amounts are in millions of dollars except per-share data and percentages.
| Metric | Three months ended Dec. 31, 2021 | Prior comparable quarter | Nine months ended Dec. 31, 2021 | Prior comparable nine months |
|---|---|---|---|---|
| Revenue | $702 | $639 | $2,080 | $1,879 |
| Gross profit / margin | $597 / 85% | $552 / 86% | $1,773 / 85% | $1,616 / 86% |
| Operating income / margin | $302 / 43% | $280 / 44% | $876 / 42% | $630 / 34% |
| Income from continuing operations | $202 | $173 | $716 | $488 |
| Net income | $202 | $178 | $716 | $360 |
| Diluted EPS | $0.34 | $0.30 | $1.21 | $0.60 |
| Cash from operating activities | $330 | $293 | $648 | $350 |
Quarterly revenue rose 10%; nine-month revenue rose 11%. Both consumer security and identity/information protection contributed: quarterly revenue was $418 and $284, respectively, versus $378 and $261 a year earlier. Management attributed growth to more direct customers and Avira revenue. Direct customer count at quarter-end increased to 23.4 million from 21.0 million, while direct ARPU declined to $8.87 from $9.10.
Quarterly operating income improved by $22, mainly on revenue growth, partly offset by higher cost of revenue and advertising. Nine-month operating income increased by $246, reflecting revenue growth, lower restructuring costs and G&A efficiencies, partly offset by higher cost of revenue and advertising. Nine-month net income also reflects the absence of the prior-year $128 loss from discontinued operations. Gross margin declined one percentage point in both comparisons; quarterly operating margin declined one point.
For the nine months, investing activities provided $316, including $355 proceeds from the Mountain View property sale, partly offset by a $39 acquisition payment. The property sale generated a $175 gain. Financing activities used $116, including $230 of dividends paid; the period also included $512 of debt proceeds and $391 of debt repayments. Cash and short-term investments were $1,781 at December 31, 2021, up from $951 at April 2, 2021. Current assets were $2,157 and current liabilities $2,883. Total debt principal was $3,855 ($3,843 carrying value), including $1,086 classified as current; the $1 billion revolver was undrawn. Stockholders’ deficit was $98. The company reported compliance with debt covenants.
Material changes, outlook and risks
- Avast proposed merger: The estimated purchase price was $8.1–$8.6 billion, subject to shareholder elections. The company expected to fund the transaction with cash, operating cash flow and new debt; definitive facility commitments were repriced and increased by $500 million on January 28, 2022. Closing was then expected February 24, 2022, subject to remaining regulatory approvals and customary conditions. A $100–$300 million break fee could apply in specified circumstances.
- Management outlook: No numerical operating guidance is provided in the supplied filing text. Management stated existing cash, expected operating cash flow and available credit should cover working capital and ongoing needs for at least 12 months, and expected those resources and new facilities to meet the merger’s cash requirements. Future liquidity remains exposed to economic conditions, acquisition costs and other risks.
- Legal matters: The company accrued $50 million as the low end of probable estimated losses in the GSA litigation, including the $0.5 million Florida settlement; it disclosed a reasonable possibility of losses above the accrual. A securities class-action settlement of $70 million was preliminarily approved, with $67.1 million covered by insurance; final approval remained pending. The SEC investigation continued, and the company said it could not estimate potential loss. An opt-out investor lawsuit and stayed derivative actions also remained unresolved.
- Other exposures: The company disclosed ongoing Log4j vulnerability remediation, uncertainty from COVID-19 and possible recession-related effects on demand and retention, intense competition, customer-retention and freemium-conversion challenges, and reliance on Broadcom for certain engineering and threat-response services. It also reported $1,012 million of long-term income taxes payable, including $571 million for uncertain tax positions, with timing and ultimate amounts uncertain.
- Capital returns and unusual items: A $0.125-per-share dividend was declared for payment in March 2022. No shares were repurchased in the first nine months; $1,774 million remained authorized. The $175 million property-sale gain materially benefited nine-month other income.
Most important facts for investors to verify
- Whether Avast obtained all required approvals and closed on the expected terms, and the resulting debt, dilution and integration effects.
- The status and potential outcome of the GSA case, SEC investigation, securities settlement and opt-out investor litigation, including any losses above recorded accruals.
- Whether customer growth can continue while direct ARPU is declining, and whether Avira freemium users convert to paid subscriptions.
- Debt maturities, refinancing capacity and liquidity after funding the merger; the filing lists $3,855 million of debt principal and $1,086 million as current.
- How much reported earnings and cash-flow improvement depends on one-time property gains, lower restructuring costs and prior-period discontinued-operation losses.